CLDN6 and cancer: However, in triple-negative breast cancer cells MDA-MB-231, GSTP1 is lost, CLDN6 enhances chemoresistance to ADM via activating the AF-6/ERK signaling pathway and up-regulating cancer stem cell characters [72].